Your browser doesn't support javascript.
loading
RIG-I immunotherapy overcomes radioresistance in p53-positive malignant melanoma.
Lambing, Silke; Tan, Yu Pan; Vasileiadou, Paraskevi; Holdenrieder, Stefan; Müller, Patrick; Hagen, Christian; Garbe, Stephan; Behrendt, Rayk; Schlee, Martin; van den Boorn, Jasper G; Bartok, Eva; Renn, Marcel; Hartmann, Gunther.
Afiliação
  • Lambing S; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn 53127, Germany.
  • Tan YP; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn 53127, Germany.
  • Vasileiadou P; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn 53127, Germany.
  • Holdenrieder S; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn 53127, Germany.
  • Müller P; Institute of Laboratory Medicine, German Heart Centre, Munich 80636, Germany.
  • Hagen C; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn 53127, Germany.
  • Garbe S; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn 53127, Germany.
  • Behrendt R; Department of Radiation Oncology, University Hospital Bonn, Bonn 53127, Germany.
  • Schlee M; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn 53127, Germany.
  • van den Boorn JG; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn 53127, Germany.
  • Bartok E; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn 53127, Germany.
  • Renn M; Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn 53127, Germany.
  • Hartmann G; Unit of Experimental Immunology, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp 2000, Belgium.
J Mol Cell Biol ; 15(1)2023 06 01.
Article em En | MEDLINE | ID: mdl-36626927

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Proteína Supressora de Tumor p53 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Proteína Supressora de Tumor p53 Idioma: En Ano de publicação: 2023 Tipo de documento: Article